Patents by Inventor Amy Aspelund

Amy Aspelund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INFLUENZA VIRUS ENCODING A TRUNCATED NS1 PROTEIN AND A SARS-COV RECEPTOR BINDING DOMAIN
    Publication number: 20230414745
    Abstract: The present invention refers to a recombinant influenza vims encoding a fusion protein comprising a truncated NS1 protein and a SARS-CoV receptor binding domain, specifically a SARS-CoV-2 RBD, and its use for prophylactic treatment, a pharmaceutical preparation comprising said virus for use in prime boost vaccination and a two-component vaccine for prime boost vaccination.
    Type: Application
    Filed: November 17, 2021
    Publication date: December 28, 2023
    Inventors: Amy ASPELUND, Thomas MUSTER, Markus WOLSCHEK
  • HIGH GROWTH INFLUENZA VIRUS
    Publication number: 20220160863
    Abstract: The present invention provides high growth influenza reassortant virus and high growth influenza reassortant virus vectors comprising amino acid modifications in the PB2, PB1, M1 and/or NS2 proteins which exhibit highly increased growth rates compared to unmodified influenza virus. Further provided are pharmaceutical compositions comprising reassortant virus and viral vectors comprising said modifications and their use for vaccination purposes.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 26, 2022
    Inventors: Thomas MUSTER, Amy ASPELUND, Markus WOLSCHEK
  • Subgroup B adenoviral vectors for treating disease
    Publication number: 20050036989
    Abstract: Methods and compositions for treating disease using human subgroup B adenovirus, vectors derived from such viruses, including expression vector systems in which one or more subgroup B adenoviral genes are replaced by a foreign gene.
    Type: Application
    Filed: June 22, 2004
    Publication date: February 17, 2005
    Applicant: Onyx Pharmaceuticals, Inc.
    Inventors: Jerry Shen, Annie Shen, Aleida Perez, Elizabeth Sevilla, Amy Aspelund